← FDA Drug Approvals (Drugs@FDA)
XARACOLL
NDA · New Drug Application · Sponsor: INNOCOLL PHARMS · Approved 2020-08-28
Drug application
- FDA Application #
NDA209511- Application type
- New Drug Application
- Brand name
- XARACOLL
- Generic name
- Bupivacaine Hydrochloride
- Active ingredients
- BUPIVACAINE HYDROCHLORIDE
- Dosage form
- IMPLANT
- Route
- IMPLANTATION
- Marketing status
- Discontinued
- Sponsor
- INNOCOLL PHARMS
- First approval
- 2020-08-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown